← Back to Search

Other

Treatment for Sarcoma

Phase 1
Waitlist Available
Research Sponsored by CBA Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

Summary

This trial is looking at whether a combination of two drugs, CBT-1 and doxorubicin, is effective in treating a type of cancer called metastatic, unresectable sarcoma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Disease Control Rate (DCR) of CBT-1® when combined with doxorubicin

Find a Location

Who is running the clinical trial?

CBA ResearchLead Sponsor
1 Previous Clinical Trials
214 Total Patients Enrolled
~6 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top